Ahmed Y. Abdelbadee Hefnawy, Obstetrics and Gynecology Specialist Trainee at Nottingham University Hospitals NHS Trust and Obstetrics and Gynecology Lecturer at Assiut University, shared a post on LinkedIn:
“Whether you’re a surgeon, a medical oncologist, or a patient advocate, the latest updates from the ESGO 2026 new Ovarian cancer guideline are: excellence in ovarian cancer care is built on specialization and holistic support.
Two recommendations from the newly released general recommendations stood out as essential for every clinical team to adopt from a cancer survivor perspective:
- Timely Referral to Specialized Centers: Patients with suspected primary or recurrent tubo-ovarian carcinoma should be referred to a gynecologic oncology center in a timely manner. It is also recommended that patients be informed if the center holds national or international accreditation, such as ESGO accreditation [III, A].
- Active Promotion of Support Groups: Beyond the operating room and the infusion suite, patient support groups should be promoted to provide assistance and guidance for patients, their families, and relatives throughout the entire treatment journey and beyond [IV, A].”
Other articles featuring Ahmed Y. Abdelbadee Hefnawy on OncoDaily.
